Newton F. Crenshaw
Newton F. Crenshaw became Vice President - Lilly Oncology Global Business Development and Advocacy for Eli Lilly and Company (Lilly) in July, 2011. He had previously served as Global business-to-payer, bio-medicines & corporate affairs and Crenshaw is a member of the company’s senior management council.
He received a Bachelor of Arts degree with honors in economics from DePauw University in 1985, where he was named a Management Fellow in the university’s honors program in the Center of Management and Entrepreneurship.
Crenshaw joined Lilly in 1985 as a sales representative in Charlottesville, Virginia. In 1988, he became a marketing analyst and served as a government pricing associate in 1989. Later that year, he was named manager of the Nashville district. In 1992, he became manager of marketing research (oral antibiotics and central nervous system). Two years later, he was named regional sales director of the south central area.
Crenshaw served as team leader of business-to-business customer strategy and implementation in 1997, where he built the company’s business-to-business capability in the U.S. market. He was promoted to vice president, U.S. sales and marketing (primary care and neuroscience), in 1999. He was named vice president of e.Lilly, which was formed in July 2000 to accelerate the use of new business models through the use of digital technologies, as well as the initiation of Lilly’s first venture investment fund. In August 2002, he became vice president of communications and public affairs. He served as president and general manager of Lilly Japan from August 2003 to July 2008. In July 2008, he became vice president, global public policy, pricing, reimbursement & access (PRA) and international corporate affairs. Crenshaw serves on several outside boards and chaired PhRMA’s executive committee in Japan.